Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial
NCT07513519 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800
Last updated 2026-04-07
Summary
This research study will use a hybrid effectiveness-implementation type 1 design to assess effectiveness of the Spotfire R/ST assay in the urgent care setting. A hybrid effectiveness-implementation type 1 study primarily focuses on the effectiveness of an intervention (e.g., use of Spotfire R/ST) but also simultaneously allows for the collection of data on the barriers and facilitators of implementing the Spotfire R/ST test in the real-world urgent care setting.
Conditions
- Acute Respiratory Infections (ARIs)
Interventions
- DEVICE
-
SPOTFIRE R/ST Diagnostic Test
At the intervention site, subjects meeting the inclusion and exclusion criteria, and who provide consent to participate in the study, will have a respiratory sample tested on the SPOTFIRE R/ST Panel, with results used by the treating clinician to guide management . At the end of the visit, enrolled patients will take a satisfaction survey, based on the AHRQ-validated CAHPS survey
Sponsors & Collaborators
-
BioMérieux
lead INDUSTRY
Principal Investigators
-
Andrea Prinzi, PhD · BioMérieux
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-22
- Primary Completion
- 2026-04-30
- Completion
- 2026-04-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Rapid Identification of Mycobacteria in Acid-fast Bacilli Smear-positive Respiratory Specimens
NCT00999076 ·Status: TERMINATED
-
Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples
NCT06531031 ·Status: NOT_YET_RECRUITING
-
Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)
NCT06271655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.
NCT00910871 ·Status: COMPLETED ·Phase: PHASE2
-
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629 ·Status: COMPLETED ·Phase: PHASE2
-
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
NCT05979545 ·Status: RECRUITING ·Phase: PHASE4
-
Impact of Rapid Detection of MRSA
NCT02027389 ·Status: WITHDRAWN
-
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
NCT04832932 ·Status: ACTIVE_NOT_RECRUITING
-
Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)
NCT04610515 ·Status: COMPLETED
-
Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)
NCT07393438 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
INSPIRE Trial for Skin and Soft Tissue Infections
NCT05423756 ·Status: COMPLETED ·Phase: NA
-
Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection
NCT07429162 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
NCT00523926 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients
NCT02862262 ·Status: COMPLETED ·Phase: NA
-
Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)
NCT02684422 ·Status: COMPLETED
-
Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives
NCT01184339 ·Status: COMPLETED
-
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test
NCT05506618 ·Status: COMPLETED
-
TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
NCT00449644 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Standard of Care Guidelines for Mycoplasma Genitalium Infections Among Men With Non-gonococcal Urethritis
NCT03910907 ·Status: TERMINATED
-
Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers
NCT05203068 ·Status: COMPLETED ·Phase: NA
-
PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19)
NCT04613310 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
NCT00002085 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Phototherapy System to Treat H Pylori
NCT00306280 ·Status: UNKNOWN ·Phase: NA
-
Effective Antibiotic Treatment of MRSA
NCT00388310 ·Status: COMPLETED ·Phase: NA
-
Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting
NCT01053598 ·Status: COMPLETED